Quick answers
- What is Bethanechol chloride used for?
- The FDA-approved label (Bethanechol Chloride, Amneal Pharmaceuticals of New York LLC, January 29, 2026) says: “Bethanechol chloride tablets are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Bethanechol chloride have a boxed warning?
- No. None of the 5 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Bethanechol chloride?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Bethanechol chloride been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Bethanechol chloride?
- 6 companies list prescription products of Bethanechol chloride in the FDA NDC Directory, including Amneal Pharmaceuticals LLC, Upsher-Smith Laboratories, LLC and Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc..
What Bethanechol chloride is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Bethanechol chloride tablets are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
— FDA label: Bethanechol Chloride, Amneal Pharmaceuticals of New York LLC, effective January 29, 2026. Read the full label on DailyMed →
The FDA has 5 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 5 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet |
|---|---|
| Route | Oral |
| Prescription products | 22 in the FDA NDC Directory |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| bethanechol chloride 10 mg tablet | Generic | $0.1484 per tablet |
| bethanechol chloride 25 mg tablet | Generic | $0.1787 per tablet |
| bethanechol chloride 5 mg tablet | Generic | $0.1208 per tablet |
| bethanechol chloride 50 mg tablet | Generic | $0.2642 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Amneal Pharmaceuticals LLC4 products
- Upsher-Smith Laboratories, LLC4 products
- Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.4 products
- Chartwell RX, LLC4 products
- Amneal Pharmaceuticals of New York LLC4 products
- American Health Packaging2 products
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (7)
- ANDA040633Upsher Smith Labs · June 1, 2005
- ANDA040634Upsher Smith Labs · June 1, 2005
- ANDA040635Upsher Smith Labs · June 1, 2005
- ANDA040636Upsher Smith Labs · June 1, 2005
- ANDA040728Chartwell Rx · October 26, 2007
- ANDA040855Amneal Pharm · November 21, 2007
- ANDA091256Heritage Pharma · May 4, 2010
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
| RxCUI (RxNorm) | 857321, 857328, 857336, 857340 |
|---|---|
| SPL set ID of the quoted label | 16523451-cd3d-4c10-be06-d59a6f12ac68 |
| FDA labels (SPL) | 5 |
| FDA applications | 7 ANDA |
| Active ingredients (FDA) | BETHANECHOL |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Bethanechol Chloride, Amneal Pharmaceuticals of New York LLC, effective January 29, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →